MedTrace Logo

A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU

NCT07249619 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-11-25

No results posted yet for this study

Summary

As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered.

Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.

Conditions

  • Subarachnoid Haemorrhagic Stroke

Interventions

OTHER

Routine Therapy (Medical, environmental accodamation, face-to-face commucation)

In the treatment of delirium, a treatment program will be implemented in line with the recommendations of international guidelines.

PROCEDURE

Biopsychosocial-Based Multimodal Approach

Delirium treatment will be implemented in accordance with international guidelines. Additionally, a basic body awareness therapy and communication program will be implemented.

Sponsors & Collaborators

  • Emre Şenocak

    lead OTHER

Principal Investigators

  • Hülya Ulusoy, PhD · Karadeniz Technical University

  • Nurel Ertürk, PhD · Tarsus University

  • Gizem Ergün, Physiotherapist · Karadeniz Technical University

  • Neslihan Hatınoğlu, PhD · Karadeniz Technical University

  • Müge Koşucu, PhD · Karadeniz Technical University

  • Duygu Yıldırım, Phyiotherapist · Trabzon Kanuni Training and Research Hospital

  • Arzu Erden Güner, PhD · Karadeniz Technical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-02
Primary Completion
2028-01-02
Completion
2028-01-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07249619 on ClinicalTrials.gov